Page last updated: 2024-08-26

cv 3988 and Peptic Ulcer

cv 3988 has been researched along with Peptic Ulcer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lagente, V; Steel, G; Vargaftig, B; Wallace, JL; Whittle, BJ1
Wallace, JL; Whittle, BJ1

Other Studies

2 other study(ies) available for cv 3988 and Peptic Ulcer

ArticleYear
Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists.
    Gastroenterology, 1987, Volume: 93, Issue:4

    Topics: Animals; Blood Pressure; Disease Models, Animal; Diterpenes; Escherichia coli Infections; Ethanol; Ginkgolides; Glyceryl Ethers; Intestine, Small; Lactones; Lipopolysaccharides; Male; Peptic Ulcer; Peptic Ulcer Hemorrhage; Phospholipid Ethers; Plant Extracts; Platelet Activating Factor; Rats; Rats, Inbred Strains; Shock, Septic; Stomach; Thiazoles

1987
Prevention of endotoxin-induced gastrointestinal damage by CV-3988, an antagonist of platelet-activating factor.
    European journal of pharmacology, 1986, May-13, Volume: 124, Issue:1-2

    Topics: Animals; Blood Pressure; Endotoxins; Lipopolysaccharides; Male; Peptic Ulcer; Phospholipid Ethers; Platelet Activating Factor; Rats; Rats, Inbred Strains; Salmonella typhi; Thiazoles

1986